198 related articles for article (PubMed ID: 10962364)
41. [Efficacy and cardiovascular tolerability of minotricon in the treatment of seborrheic alopecia].
Rigoni C; Pinelli S; Toffolo P; Scarabelli G; Terenzio C
G Ital Dermatol Venereol; 1990 Oct; 125(10):XLVII-LIII. PubMed ID: 2150507
[TBL] [Abstract][Full Text] [Related]
42. Therapeutic effects of minoxidil high extra combination therapy in patients with androgenetic alopecia.
Pazoki-Toroudi H; Babakoohi S; Nilforoushzadeh MA; Nassiri-Kashani M; Shizarpour M; Ajami M; Habibey R; Sadr B; Rashighi-Firoozabadi M; Firooz A
Skinmed; 2012; 10(5):276-82. PubMed ID: 23163069
[No Abstract] [Full Text] [Related]
43. Differences in reproductive toxicology between alopecia drugs: an analysis on adverse events among female and male cases.
Wu M; Yu Q; Li Q
Oncotarget; 2016 Dec; 7(50):82074-82084. PubMed ID: 27738338
[TBL] [Abstract][Full Text] [Related]
44. [It is difficult to predict the effect of minoxidil liniment on hair loss in men].
Anderson C; Berne B; Juhlin L; Skogh M; Strand A; Vahlquist A
Lakartidningen; 1990 Jan; 87(1-2):16-7. PubMed ID: 2405223
[No Abstract] [Full Text] [Related]
45. [Androgenetic alopecia].
del Marmol V; Jouanique C
Rev Med Brux; 2004 Sep; 25(4):A277-81. PubMed ID: 15516056
[TBL] [Abstract][Full Text] [Related]
46. Frontal fibrosing alopecia: a survey in 16 patients.
Moreno-Ramírez D; Camacho Martínez F
J Eur Acad Dermatol Venereol; 2005 Nov; 19(6):700-5. PubMed ID: 16268874
[TBL] [Abstract][Full Text] [Related]
47. [The therapy of androgenetic alopecia with minoxidil].
Bammel A; Stern R; Sterry W
Dtsch Med Wochenschr; 1993 May; 118(21):787-9. PubMed ID: 8504714
[No Abstract] [Full Text] [Related]
48. A review of hormonal therapy for female pattern (androgenic) alopecia.
Scheinfeld N
Dermatol Online J; 2008 Mar; 14(3):1. PubMed ID: 18627703
[TBL] [Abstract][Full Text] [Related]
49. Understanding and managing common baldness.
Tran D; Sinclair RD
Aust Fam Physician; 1999 Mar; 28(3):248-50, 252-3. PubMed ID: 10098304
[TBL] [Abstract][Full Text] [Related]
50. Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia.
Price VH; Roberts JL; Hordinsky M; Olsen EA; Savin R; Bergfeld W; Fiedler V; Lucky A; Whiting DA; Pappas F; Culbertson J; Kotey P; Meehan A; Waldstreicher J
J Am Acad Dermatol; 2000 Nov; 43(5 Pt 1):768-76. PubMed ID: 11050579
[TBL] [Abstract][Full Text] [Related]
51. Long-term (5-year) multinational experience with finasteride 1 mg in the treatment of men with androgenetic alopecia.
Finasteride Male Pattern Hair Loss Study Group
Eur J Dermatol; 2002; 12(1):38-49. PubMed ID: 11809594
[TBL] [Abstract][Full Text] [Related]
52. Topical minoxidil for baldness: a reappraisal.
Med Lett Drugs Ther; 1994 Jan; 36(914):9-10. PubMed ID: 8277913
[No Abstract] [Full Text] [Related]
53. Safety of topical minoxidil solution: a one-year, prospective, observational study.
Shapiro J
J Cutan Med Surg; 2003; 7(4):322-9. PubMed ID: 14735400
[TBL] [Abstract][Full Text] [Related]
54. Oral finasteride improved the quality of life of androgenetic alopecia patients.
Yamazaki M; Miyakura T; Uchiyama M; Hobo A; Irisawa R; Tsuboi R
J Dermatol; 2011 Aug; 38(8):773-7. PubMed ID: 21806672
[TBL] [Abstract][Full Text] [Related]
55. Topical minoxidil useful in 18% of patients with androgenetic alopecia: a study of 430 cases.
Tosti A
Dermatologica; 1986; 173(3):136-8. PubMed ID: 3770260
[TBL] [Abstract][Full Text] [Related]
56. Human genetics. Hair apparent.
Davies K
Nature; 1998 Feb; 391(6667):537, 539. PubMed ID: 9468131
[No Abstract] [Full Text] [Related]
57. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss.
Lucky AW; Piacquadio DJ; Ditre CM; Dunlap F; Kantor I; Pandya AG; Savin RC; Tharp MD
J Am Acad Dermatol; 2004 Apr; 50(4):541-53. PubMed ID: 15034503
[TBL] [Abstract][Full Text] [Related]
58. Value of hormonal levels in patients with male androgenetic alopecia treated with finasteride: better response in patients under 26 years old.
Camacho FM; García-Hernández MJ; Fernández-Crehuet JL
Br J Dermatol; 2008 May; 158(5):1121-4. PubMed ID: 18363752
[TBL] [Abstract][Full Text] [Related]
59. Adverse effects of low-dose oral minoxidil for androgenetic alopecia in 435 patients.
Sanabria B; Vanzela TN; Miot HA; Müller Ramos P
J Am Acad Dermatol; 2021 Apr; 84(4):1175-1178. PubMed ID: 33253848
[No Abstract] [Full Text] [Related]
60. 5 alpha-reductase and finasteride in pattern alopecia and acne.
Burkhart CG; Burkhart CN
J Drugs Dermatol; 2004; 3(4):363-4. PubMed ID: 15303779
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
